First Manhattan’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $246K | Sell |
1,942
-4
| -0.2% | -$506 | ﹤0.01% | 649 |
|
2025
Q1 | $249K | Sell |
1,946
-498
| -20% | -$63.7K | ﹤0.01% | 616 |
|
2024
Q4 | $323K | Buy |
+2,444
| New | +$323K | ﹤0.01% | 588 |
|
2024
Q2 | – | Sell |
-540
| Closed | -$74.1K | – | 950 |
|
2024
Q1 | $74.1K | Hold |
540
| – | – | ﹤0.01% | 814 |
|
2023
Q4 | $73.4K | Hold |
540
| – | – | ﹤0.01% | 799 |
|
2023
Q3 | $66K | Hold |
540
| – | – | ﹤0.01% | 820 |
|
2023
Q2 | $68.6K | Hold |
540
| – | – | ﹤0.01% | 830 |
|
2023
Q1 | $69.7K | Hold |
540
| – | – | ﹤0.01% | 865 |
|
2022
Q4 | $70.9K | Hold |
540
| – | – | ﹤0.01% | 881 |
|
2022
Q3 | $63K | Sell |
540
-600
| -53% | -$70K | ﹤0.01% | 897 |
|
2022
Q2 | $134K | Hold |
1,140
| – | – | ﹤0.01% | 786 |
|
2022
Q1 | $148K | Buy |
1,140
+540
| +90% | +$70.1K | ﹤0.01% | 813 |
|
2021
Q4 | $91K | Hold |
600
| – | – | ﹤0.01% | 889 |
|
2021
Q3 | $97K | Hold |
600
| – | – | ﹤0.01% | 870 |
|
2021
Q2 | $98K | Hold |
600
| – | – | ﹤0.01% | 865 |
|
2021
Q1 | $90K | Sell |
600
-375
| -38% | -$56.3K | ﹤0.01% | 844 |
|
2020
Q4 | $147K | Sell |
975
-90
| -8% | -$13.6K | ﹤0.01% | 725 |
|
2020
Q3 | $144K | Buy |
1,065
+375
| +54% | +$50.7K | ﹤0.01% | 696 |
|
2020
Q2 | $94K | Hold |
690
| – | – | ﹤0.01% | 780 |
|
2020
Q1 | $74K | Buy |
+690
| New | +$74K | ﹤0.01% | 782 |
|
2019
Q3 | – | Sell |
-100
| Closed | -$10K | – | 1365 |
|
2019
Q2 | $10K | Buy |
+100
| New | +$10K | ﹤0.01% | 1182 |
|
2017
Q1 | – | Sell |
-555
| Closed | -$49K | – | 1419 |
|
2016
Q4 | $49K | Hold |
555
| – | – | ﹤0.01% | 926 |
|
2016
Q3 | $53K | Hold |
555
| – | – | ﹤0.01% | 912 |
|
2016
Q2 | $47K | Buy |
+555
| New | +$47K | ﹤0.01% | 961 |
|